BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35762231)

  • 1. OCT4 activates a Suv39h1-repressive antisense lncRNA to couple histone H3 Lysine 9 methylation to pluripotency.
    Bernard LD; Dubois A; Heurtier V; Fischer V; Gonzalez I; Chervova A; Tachtsidi A; Gil N; Owens N; Bates LE; Vandormael-Pournin S; Silva JCR; Ulitsky I; Cohen-Tannoudji M; Navarro P
    Nucleic Acids Res; 2022 Jul; 50(13):7367-7379. PubMed ID: 35762231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin.
    Ayrapetov MK; Gursoy-Yuzugullu O; Xu C; Xu Y; Price BD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9169-74. PubMed ID: 24927542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.
    Wakabayashi Y; Tamiya T; Takada I; Fukaya T; Sugiyama Y; Inoue N; Kimura A; Morita R; Kashiwagi I; Takimoto T; Nomura M; Yoshimura A
    J Biol Chem; 2011 Oct; 286(41):35456-35465. PubMed ID: 21862595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
    Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
    Vaquero A; Scher M; Erdjument-Bromage H; Tempst P; Serrano L; Reinberg D
    Nature; 2007 Nov; 450(7168):440-4. PubMed ID: 18004385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericentric H3K9me3 Formation by HP1 Interaction-defective Histone Methyltransferase Suv39h1.
    Muramatsu D; Kimura H; Kotoshiba K; Tachibana M; Shinkai Y
    Cell Struct Funct; 2016 Dec; 41(2):145-152. PubMed ID: 27733730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
    Cai L; Ma X; Huang Y; Zou Y; Chen X
    Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of nucleic acid and methylated H3K9 binding activities of Suv39h1 on its heterochromatin assembly.
    Shirai A; Kawaguchi T; Shimojo H; Muramatsu D; Ishida-Yonetani M; Nishimura Y; Kimura H; Nakayama JI; Shinkai Y
    Elife; 2017 Aug; 6():. PubMed ID: 28760201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1.
    Zhao M; Wu X; Zhang Q; Luo S; Liang G; Su Y; Tan Y; Lu Q
    Arthritis Res Ther; 2010; 12(6):R227. PubMed ID: 21192791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zfp296 negatively regulates H3K9 methylation in embryonic development as a component of heterochromatin.
    Matsuura T; Miyazaki S; Miyazaki T; Tashiro F; Miyazaki JI
    Sci Rep; 2017 Sep; 7(1):12462. PubMed ID: 28963472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericentric heterochromatin generated by HP1 protein interaction-defective histone methyltransferase Suv39h1.
    Muramatsu D; Singh PB; Kimura H; Tachibana M; Shinkai Y
    J Biol Chem; 2013 Aug; 288(35):25285-25296. PubMed ID: 23836914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone methyltransferase Suv39h regulates 3T3-L1 adipogenesis.
    Jing J; Li F; Zha L; Yang X; Wu R; Wang S; Xue B; Shi H
    Adipocyte; 2020 Dec; 9(1):401-414. PubMed ID: 32698678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CK2 downregulation induces senescence-associated heterochromatic foci formation through activating SUV39h1 and inactivating G9a.
    Park JW; Kim JJ; Bae YS
    Biochem Biophys Res Commun; 2018 Oct; 505(1):67-73. PubMed ID: 30241941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-state activation mechanism controls the histone methyltransferase Suv39h1.
    Müller MM; Fierz B; Bittova L; Liszczak G; Muir TW
    Nat Chem Biol; 2016 Mar; 12(3):188-93. PubMed ID: 26807716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex.
    Fritsch L; Robin P; Mathieu JR; Souidi M; Hinaux H; Rougeulle C; Harel-Bellan A; Ameyar-Zazoua M; Ait-Si-Ali S
    Mol Cell; 2010 Jan; 37(1):46-56. PubMed ID: 20129054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered telomere homeostasis and resistance to skin carcinogenesis in Suv39h1 transgenic mice.
    Petti E; Jordi F; Buemi V; Dinami R; Benetti R; Blasco MA; Schoeftner S
    Cell Cycle; 2015; 14(9):1438-46. PubMed ID: 25789788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for tyrosine phosphorylation of SUV39H1 histone methyltransferase in enhanced trimethylation of histone H3K9 via neuregulin-1/ErbB4 nuclear signaling.
    Nakajo H; Ishibashi K; Aoyama K; Kubota S; Hasegawa H; Yamaguchi N; Yamaguchi N
    Biochem Biophys Res Commun; 2019 Apr; 511(4):765-771. PubMed ID: 30833073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.
    Scarola M; Comisso E; Pascolo R; Chiaradia R; Marion RM; Schneider C; Blasco MA; Schoeftner S; Benetti R
    Nat Commun; 2015 Jul; 6():7631. PubMed ID: 26158551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.
    Yokoyama Y; Hieda M; Nishioka Y; Matsumoto A; Higashi S; Kimura H; Yamamoto H; Mori M; Matsuura S; Matsuura N
    Cancer Sci; 2013 Jul; 104(7):889-95. PubMed ID: 23557258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes.
    Villeneuve LM; Reddy MA; Lanting LL; Wang M; Meng L; Natarajan R
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9047-52. PubMed ID: 18579779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.